A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

Autor: Martin, P. *, Jung, S.-H., Pitcher, B., Bartlett, N.L., Blum, K.A., Shea, T., Hsi, E.D., Ruan, J., Smith, S.E., Leonard, J.P., Cheson, B.D.
Zdroj: In Annals of Oncology November 2017 28(11):2806-2812
Databáze: ScienceDirect